According to TipRanks, Rich is a 3-star analyst with an average return of 6.0% and a 56.90% success rate. Rich covers the Healthcare sector, focusing on stocks such as Idexx Laboratories, Zoetis, and Alignment Healthcare.
Alignment Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $20.29, representing a 13.67% upside. In a report released today, Bank of America Securities also maintained a Buy rating on the stock with a $23.00 price target.
The company has a one-year high of $23.35 and a one-year low of $6.14. Currently, Alignment Healthcare has an average volume of 436.5K.
Based on the recent corporate insider activity of 61 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ALHC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which they receive healthcare coverage and services on an annual basis.
Read More on ALHC:
- Morgan Stanley Sticks to Their Hold Rating for NanoString Tech (NSTG)
- Morgan Stanley Keeps Their Sell Rating on Shift4 Payments (FOUR)
- Yelp (YELP) Receives a Rating Update from a Top Analyst
- Doximity (DOCS) Receives a Buy from Goldman Sachs
- Morgan Stanley Reaffirms Their Buy Rating on Ingersoll Rand (IR)